Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Julie Bellemans

Awards & Distinctions

9 Results

2024

Chitin-mediated blockade of chitinase-like proteins reduces tumor immunosuppression, inhibits lymphatic metastasis and enhances anti-PD-1 efficacy in complementary TNBC models

Robbe SalembierCaro De HaesJulie BellemansKristel DemeyereWim Van Den BroeckNiek SandersSteven Van LaereTraci R. LyonsEvelyne MeyerJonas Steenbrugge

A1 Journal Article in BREAST CANCER RESEARCH

Endolysin NC5 improves early cloxacillin treatment in a mouse model of Streptococcus uberis mastitis

Niels Vander ElstJulie BellemansRob LavigneYves BriersEvelyne Meyer

A1 Journal Article in APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

2023

Characterization of the immune landscape of canine and feline mammary tumors as a basis for candidate biomarker, drug and toxicity studies

Jonas SteenbruggeCaro De HaesJulie BellemansKristel DemeyereHilde De RoosterEvelyne Meyer

Endolysin NC5 improves early cloxacillin treatment in a mouse model for bovine Streptococcus uberis mastitis

Julie BellemansNiels Vander ElstRob LavigneYves BriersEvelyne Meyer

Priming of the murine mammary gland with Staphylococcus chromogenes IM reduces bacterial growth of Streptococcus uberis : a proof-of-concept study

Niels Vander ElstJulie BellemansJonas SteenbruggeChloë GeeromsKoen BreyneSofie PiepersBruno Toledo-SilvaFernando Nogueira De SouzaFreddy HaesebrouckSarne De Vliegher et al.

A1 Journal Article in VETERINARY RESEARCH

2022

Chitin immunomodulation stimulates anti-PD-1 therapy in an intraductal model for triple-negative breast cancer

Jonas SteenbruggeJulie BellemansKristel DemeyereNiek SandersEvelyne Meyer

One cisplatin dose provides durable stimulation of anti-tumor immunity and alleviates anti-PD-1 resistance in an intraductal model for triple-negative breast cancer

Jonas SteenbruggeJulie BellemansNiels Vander ElstKristel DemeyereJosephine De VliegherTimothy PereraOlivier De WeverWim Van Den BroeckWard De SpiegelaereNiek Sanders et al.

A1 Journal Article in ONCOIMMUNOLOGY

One cisplatin dose suffices to maintain anti-tumor immunity and enhances anti-PD-1 efficacy in an intraductal model for triple-negative breast cancer

Jonas SteenbruggeJulie BellemansNiels Vander ElstKristel DemeyereNiek SandersEvelyne Meyer

Progression of canine mammary tumors is associated with an immunosuppressed microenvironment

Jonas SteenbruggeJulie BellemansLennert HeirmanAurelie De RooverKristel DemeyereHilde De RoosterEvelyne Meyer